CTI BioPharma Prices Underwritten Public Offering of $50M of Convertible Preferred Stock
October 27, 2015 at 09:15 AM EDT
CTI BioPharma Corp. ("CTI") (NASDAQ and MTA: CTIC) today announced the pricing of an underwritten public offering of 50,000 shares of ...
